从定量流量比率导向的完整血管化和血管学导向的皮肤冠状动脉干预在患有ST段升高肌肉心脏病发作的患者的结果
Žilvinas Krivickas1, Mindaugas Barauskas1, Nojus Jodka1
1Department of Cardiology, Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania.
概括
对于ST升高心肌梗塞 (STEMI) 患者的皮肤冠状动脉干预 (PCI) 的定量流量比率 (QFR) 指南显著减少了手术时间和支架使用. QFR提供了一种更有效的方法来治疗非罪祸首的病变,而不会影响患者的结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗成像医学成像
背景情况:
- 定量流量比 (QFR) 是评估冠状动脉狭窄的非侵入性工具.
- 它提供功能评估,不需要压力线或高血压.
- 这项研究评估了QFR在ST升高心肌梗塞 (STEMI) 后的非罪祸首病变管理中的作用.
研究的目的:
- 为了比较QFR指导的过程和住院患者的结果与血管学指导的皮肤冠状动脉干预 (PCI).
- 评估QFR在对STEMI患者非罪祸首病变的分阶段再血管化的疗效.
主要方法:
- 一项随机前性单中心研究,涉及124名STEMI患者,具有显著的非罪祸首狭窄症.
- 参与者被随机分配到QFR引导的PCI (n=62) 或血管学引导的PCI (n=62).
- 两个组之间比较了关键的程序指标和住院患者的结果.
主要成果:
- 以QFR为指导的PCI显示,光镜时间 (6.2分钟与8.0分钟) 和对比体积 (100毫升与120毫升) 显著减少.
- 在QFR组中,植入的支架数量也较少 (1.5 vs 2.0) 和总支架长度较短 (28 vs 45 mm).
- 在周围手术并发症或住院时间长度方面没有发现显著差异.
结论:
- 在STEMI患者的非罪祸首病变中,QFR引导的PCI提高了程序效率.
- 它导致减少光镜时间,对比度使用和支架植入.
- QFR显示了优化PCI策略的潜力,而不会影响患者的安全或结果.
更多相关视频
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
1.3K
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.5K
相关概念视频
01:28Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
01:27Coronary Artery Disease V: Interprofessional Care
39
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39
01:30Acute Coronary Syndrome I: Introduction
81
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
81